Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study.
<h4>Background and objectives</h4>Although the burden of non-alcoholic fatty liver disease (NAFLD) continues to increase worldwide, genetic factors predicting progression to cirrhosis and decompensation in NAFLD remain poorly understood. We sought to determine whether gene expression pro...
Saved in:
| Main Authors: | Kara Wegermann, Ricardo Henao, Anna Mae Diehl, Susan K Murphy, Manal F Abdelmalek, Cynthia A Moylan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2018-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0204308 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Branched-chain amino acid transferase type 2 (BCAT2) deficiency: Report of an eighth case and literature review
by: Etienne Mondésert, et al.
Published: (2025-06-01) -
A novel BCAT1 inhibitor bufalin sensitizes pancreatic cancer cells to chemotherapy
by: Wei Zhang, et al.
Published: (2025-05-01) -
SIRT5-mediated BCAT1 desuccinylation and stabilization leads to ferroptosis insensitivity and promotes cell proliferation in glioma
by: Tao Wang, et al.
Published: (2025-04-01) -
Design, Synthesis and Biological Activity Study of γ-Aminobutyric Acid (GABA) Derivatives Containing Bridged Bicyclic Skeletons as BCAT1 Inhibitors
by: Wen Luo, et al.
Published: (2025-02-01) -
Elevation of transaminases. What if not the liver?
by: I. V. Sharkova
Published: (2024-04-01)